Skip to content
OpenCapital
Get started

Agios Pharmaceuticals AGIO Income recognized in respect of BARDA

Income recognized in respect of BARDA at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$138.28M+149%
Nuvation Bio logo
Nuvation BioNUVB
$700K-63.2%
Zymeworks logo
ZymeworksZYME
$0—
PVL
Palvella TherapeuticsPVLA
$0-100%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.9M—
Nuvation Bio logo
Nuvation BioNUVB
$8.6M+359%

Segments

By segment

See full
Reportable Segment$36.79M+11.5%

Other financials

Income statement

See full
Revenue$20.7M+138%
Gross profit$19.4M+154%
Operating income-$110.0M-3.2%
Net income-$99.1M-11.0%
EPS (diluted)-$1.69-9.0%

Balance sheet

See full
Cash & equivalents$113.6M+43.9%
Total debt$35.7M-32.5%
Total equity$1.1B-24.4%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow-$118.9M-6.7%
CapEx$769.0K+0.4%
Free cash flow-$119.7M-6.6%

Valuation

See full
Market cap$2.16B+18.1%

Profitability

See full
Gross margin90%+2.5pp
Operating margin-720%-204pp
Net margin-639.8%—
FCF margin-582.5%-185pp

Returns & leverage

See full
Return on equity-32.8%—
Debt / equity0×0.0×
Current ratio14.2×-4.3×